[{"Assets_0_Q1_USD":226767000.0,"CommonStockSharesOutstanding_0_Q1_shares":129822000.0,"EarningsPerShareBasic_1_Q1_USD":-0.26,"NetIncomeLoss_1_Q1_USD":-32897000.0,"StockholdersEquity_0_Q1_USD":-58499000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":128615000.0,"Ticker":"HALO","CIK":"1159036","name":"HALOZYME THERAPEUTICS INC","OfficialName":"Halozyme Therapeutics Inc. Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"5856719603.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20170509"}]